Cargando…

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection

We assessed various newly generated compounds that target the main protease (M(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and various previously known compounds reportedly active against SARS-CoV-2, employing RNA quantitative PCR (RNA-qPCR), cytopathicity assays, and immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattori, Shin-ichiro, Higshi-Kuwata, Nobuyo, Raghavaiah, Jakka, Das, Debananda, Bulut, Haydar, Davis, David A., Takamatsu, Yuki, Matsuda, Kouki, Takamune, Nobutoki, Kishimoto, Naoki, Okamura, Tadashi, Misumi, Shogo, Yarchoan, Robert, Maeda, Kenji, Ghosh, Arun K., Mitsuya, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441487/ https://www.ncbi.nlm.nih.gov/pubmed/32820005 http://dx.doi.org/10.1128/mBio.01833-20

Ejemplares similares

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
por: Aoki, Manabu, et al.
Publicado: (2023)

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Hattori, Shin-ichiro, et al.
Publicado: (2021)

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
por: Aoki, Manabu, et al.
Publicado: (2017)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s
por: Nakata, Hirotomo, et al.
Publicado: (2019)

Identification of SARS-CoV-2 M(pro) inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2023)

Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors
por: Ghosh, Arun K., et al.
Publicado: (2021)

Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
por: Harada, Keisuke, et al.
Publicado: (2014)

Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent
por: Kumamoto, Hiroki, et al.
Publicado: (2023)

Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation
por: Davis, David A., et al.
Publicado: (2022)

0920. Cerebrovascular autoregulation in normotensive hypovolaemia: a study combining lower body negative pressure and MRI
por: Beards, SC, et al.
Publicado: (2014)

Glyceraldehyde 3-phosphate dehydrogenase negatively regulates human immunodeficiency virus type 1 infection
por: Kishimoto, Naoki, et al.
Publicado: (2012)

The C-terminal domain of glyceraldehyde 3-phosphate dehydrogenase plays an important role in suppression of tRNA(Lys3) packaging into human immunodeficiency virus type-1 particles
por: Kishimoto, Naoki, et al.
Publicado: (2016)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1
por: Misumi, Shogo, et al.
Publicado: (2010)

Royal jelly enhances antigen‐specific mucosal IgA response
por: Kai, Hikaru, et al.
Publicado: (2013)

Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration
por: Kishimoto, Naoki, et al.
Publicado: (2020)

Arginyl-tRNA-protein transferase 1 contributes to governing optimal stability of the human immunodeficiency virus type 1 core
por: Kishimoto, Naoki, et al.
Publicado: (2021)

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes
por: Takamatsu, Yuki, et al.
Publicado: (2023)

Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
por: Davis, David A., et al.
Publicado: (2021)

GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023)

ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag
por: Ogawa, Minako, et al.
Publicado: (2015)

Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
por: Bulut, Haydar, et al.
Publicado: (2020)

GrlJ, a Dictyostelium GABA(B)-like receptor with roles in post-aggregation development
por: Prabhu, Yogikala, et al.
Publicado: (2007)

Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity
por: Marti, Amelia, et al.
Publicado: (2006)

Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation
por: Higashi-Kuwata, Nobuyo, et al.
Publicado: (2022)

The putative G protein–coupled receptor GrlD mediates extracellular polyphosphate sensing in Dictyostelium discoideum
por: Suess, Patrick M., et al.
Publicado: (2019)

Structure of GrlR and the Implication of Its EDED Motif in Mediating the Regulation of Type III Secretion System in EHEC
por: Jobichen, Chacko, et al.
Publicado: (2007)

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro
por: Amano, Masayuki, et al.
Publicado: (2017)

Restoration of Neutralization Activity Against Omicron BA.2 and BA.5 in Older Adults and Individuals With Risk Factors Following the Fourth Dose of Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Vaccine
por: Amano, Masayuki, et al.
Publicado: (2022)

Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
por: Aoki, Manabu, et al.
Publicado: (2018)

An Autocrine Proliferation Repressor Regulates Dictyostelium discoideum Proliferation and Chemorepulsion Using the G Protein-Coupled Receptor GrlH
por: Tang, Yu, et al.
Publicado: (2018)

In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023)

Screening of Anti-Adhesion Agents for Pathogenic Escherichia coli O157:H7 by Targeting the GrlA Activator
por: Hong, Sin Young, et al.
Publicado: (2023)

Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition
por: Amano, Masayuki, et al.
Publicado: (2019)

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
por: Fu, Ziyang, et al.
Publicado: (2021)

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
por: Takamatsu, Yuki, et al.
Publicado: (2022)

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron
por: Amano, Masayuki, et al.
Publicado: (2023)

Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor
por: Hu, Guodong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8bvv67dhr0eismg2ncmghkb5mo